Richardson, E;
Stockwell, SR;
Li, H;
Aherne, W;
Cuomo, ME;
Mittnacht, S;
(2012)
Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response.
PLOS ONE
, 7
(2)
, Article e31627. 10.1371/journal.pone.0031627.
Preview |
PDF
1370347.pdf Download (993kB) |
Abstract
DNA damage activates checkpoint controls which block progression of cells through the division cycle. Several different checkpoints exist that control transit at different positions in the cell cycle. A role for checkpoint activation in providing resistance of cells to genotoxic anticancer therapy, including chemotherapy and ionizing radiation, is widely recognized. Although the core molecular functions that execute different damage activated checkpoints are known, the signals that control checkpoint activation are far from understood. We used a kinome-spanning RNA interference screen to delineate signalling required for radiation-mediated retinoblastoma protein activation, the recognized executor of G1 checkpoint control. Our results corroborate the involvement of the p53 tumour suppressor (TP53) and its downstream targets p21CIP1/WAF1 but infer lack of involvement of canonical double strand break (DSB) recognition known for its role in activating TP53 in damaged cells. Instead our results predict signalling involving the known TP53 phosphorylating kinase PRPK/TP53RK and the JNK/p38MAPK activating kinase STK4/MST1, both hitherto unrecognised for their contribution to DNA damage G1 checkpoint signalling. Our results further predict a network topology whereby induction of p21CIP1/WAF1 is required but not sufficient to elicit checkpoint activation. Our experiments document a role of the kinases identified in radiation protection proposing their pharmacological inhibition as a potential strategy to increase radiation sensitivity in proliferating cancer cells.
Type: | Article |
---|---|
Title: | Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1371/journal.pone.0031627 |
Publisher version: | http://dx.doi.org/10.1371/journal.pone.0031627 |
Language: | English |
Additional information: | © 2012 Richardson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This work was supported through Cancer Research UK grant numbers CRC278X and CRM048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Cancer Bio |
URI: | https://discovery.ucl.ac.uk/id/eprint/1370347 |
Archive Staff Only
View Item |